indicate that the window of opportunity for effective disease modification using antiinflammatory therapies could be limited.
More than two decades ago, the field of tissue engineering, built on a combinatorial plat form of cells, scaffolds, and biofactors, was conceptualized as a means to functional restoration and regeneration of diseased or damaged tissues and organs, including those of the musculoskeletal system. More recently, a number of new concepts have been developed that promise to enhance the success of cell-based and biomaterial-based tissue engineering approaches. In 2012, a number of studies exemplified these new concepts and represent key advances in the approach to regenerative medicine.
Adult mesenchymal stem cells (MSCs) represent the most widely investigated cell type for musculoskeletal tissue engineering; 1 the concept that these cells have immunoregulatory, anti-inflammatory, pro-survival, and endothelial cell modulatory activities is increasingly considered in regenerative applications, in addition to their multilineage differentiation potential. 2 In order to exert these activities in a way that will influence tissue regeneration, MSCs must first home to the target tissue and subsequently differentiate appropriately.
In a 2012 study, Guan et al. 3 developed a conjugate molecule comprising LLP2A, a peptidomimetic ligand for α4β1 integrin receptors that were found to be highly expressed on osteoprogenitor MSCs, and the bisphosphonate alendronate, which has a high affinity for bone. In vitro analyses showed that this LLP2A-alendronate conjugate (LLP2A-Ale) increased MSC migration and osteogenesis. 3 In vivo, intravenously xenotransplanted human MSCs (hMSCs) were detected adjacent to the peri osteal, endocortical and trabecular bone surfaces in the lumbar vertebral bodies of severe combined immunodeficiency mice only after co-injection with LLP2A-Ale. 3 After 3 weeks follow-up, the hMSCs were seen embedded within the bone matrix and were associated with increased bone formation. 3 Interestingly, injection of LLP2A-Ale alone also augmented bone formation; 3 the authors suggested that the 'bone-seeking' alendronate-conjugated α4β1 integrin ligand could promote homing of endogenous MSCs to bone, because LLP2A alone -which would have a nonspecific tissue distribution-was not osteogenic. 3 More importantly, injection of LLP2A-Ale alone was found to prevent trabecular bone loss in immunocompetent mice with ovariectomyinduced osteopenia, resulting in increased osteoblast and mineralizing surfaces, as well as higher rate of bone formation for the total bone surface. 3 These exciting findings demonstrate a potentially effective means of guiding MSCs to bone (Figure 1a) , and provide strong evidence that MSCs can act as functional osteoprogenitor cells in vivo. Moreover, the effects of LLP2A-Ale alone in osteo penic mice suggest that endogenous MSCs could, in fact, be adequately recruited to bone surfaces using this molecule. Studies to test the effectiveness of this approach for the treatment of bone abnormalities, such as fractures and osteoporosis, are certainly warranted. This model should also be useful to examine whether the regulatory activities of recruited MSCs also influence cells resident in the bone to cooperatively enhance bone formation.
Tissue matrices have been recognized as rich depots of molecular signals, pri marily growth factors sequestered by macromolecular components of the extra cellular matrix (ECM), which regulate tissuespecific biological activities. 4 Indeed, when used as scaffolds for seeded MSCs, hMSCderived ECM preparations, obtained by decellularizing in vitro MSC cultures, promote cell attachment, spreading, migration, proliferation, and maintenance of res ponse to differentiation signals. 5 This concept formed the basis of a different approach to optimize delivery and maintenance of MSCs that was developed in a 2012 study NATURE REVIEWS | RHEUMATOLOGY VOLUME 9 | FEBRUARY 2013 | 75
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by Zeitouni et al. 6 Injection of hMSCs, pretreated with GW9662 to suppress adipogenic activity via inhibition of peroxisome proliferator-activated receptorγ, improved bone healing in a mouse cal varial defect xeno graft model; 6 however, the effect was limited to the early osteogenic phase, and was lost during bone remodelling due to unsatis factory hMSC retention. 6 3 weeks after grafting of GW9662-treated hMSCs together with hMSC-derived ECM, increased hMSC engraftment was detected, compared with mice treated with hMSCs alone, and reproducible, near-complete repair of calvarial bone defects was seen (Figure 1b) , 6 indicating that the hMSCderived ECM acted as a retentive scaffold. In mice treated with hMSC and hMSC-derived ECM, large clusters of engrafted cells were observed that were not associated with the remodelling bone surface, 6 suggesting that the matrix-localized hMSCs provided an enabling microenvironment that promoted intrinsic bone formation within the graft. These findings strongly suggest that MSC-derived ECM should be considered as a potential adjunct component in the design of bioactive biomaterial scaffolds for tissue engineering.
Researchers are increasingly realizing that tissue or organ regeneration must recapitulate the biological mechanisms of embryonic development and tissue morpho genesis, 7 not only at a molecular level, but also in terms of the spatio temporal and physical aspects. This understanding has led to increasingly rational design of bio material scaffolds, the development of 3D tissue constructs and their propagation in bio reactors that provide more native environ ments. Because of the weight-bearing mechanical requirements of musculo skeletal tissues, a preferred bioactive scaffold would consist of a mechanically strong biomaterial scaffold, such as a bio resorbable polymer, that appropriately incorporates decellular ized ECM. Hydrogels are popular biomaterials for tissue engineering, drug delivery and model ling of ECM owing to ease of manipula tion and cell seeding prior to gelation, but are severely limited by their mechanical behaviour, particularly their low stretchability.
Sun et al. 9 recently reported a new protocol for synthesis of highly stretchable and tough hydrogels. Gelation of hydrogels is normally mediated via either ionic cross-links, such as in alginate, or covalent cross-links, such as in polyacrylamide. Sun and co-workers 9 created an alginate-polyacrylamide hybrid hydrogel, in which the two types of polymer network were intertwined and further cross-linked via covalent bonds between amine groups on polyacrylamide chains and carboxyl groups on alginate chains. The hybrid gels contained ~90% water, but could be stretched beyond 20 times their original length, and had high fracture energies of around 9,000 J/m 2 compared with 10-250 J/m 2 for alginate or polyacrylamide gels; 9 even when notches were created in the hydrogel structure, the stretchability was up to 17 times the original length. 9 The authors attributed the large improvement in hydrogel mechani cal proper ties to two factors: crack bridging by covalent cross-links and the network of ionic cross-links providing hysteresis. A nascent engineered or regenerated tissue i nitially produced by seeded cells is unlikely to exhibit, on its own, the physical properties of the mature tissue; thus, the bio material scaffold has the burden of meeting the physicomechanical requirements. In this respect, the principle of combining weak and strong cross-links between brittle constituents to produce a tough, stretchable material should be of high utility. Such an approach should minimize physical damage of the nascent engineered tissue construct and enhance its eventual maturation and integration into the host tissue.
Although ionic cross-links, mediated by divalent cations for example, are generally biocompatible, free-radicals produced dur ing chemical covalent cross-linking are cytotoxic and the reaction can also be exothermic. Photo-induced covalent cross-linking might represent a milder alternative, 10 but To be adopted for cell-based tissue engineering, these issues will need to be resolved to make hybrid hydrogels biocompatible, enabling their evaluation in direct cell-seeding protocols.
Tissue engineering and regenerative medi cine are highly active research disciplines that have seen rapid, complementary convergence of life science research, engineer ing, and clinical medicine, illustrated by the advances in MSC grafting and biomechanical scaffold design made in 2012 and described herein. The translational nature of this discipline dictates that issues such as biocompatibility, scale-up and safety must be considered, to enable preclinical and clinical trials that will lead to therapeutic product development for musculo skeletal repair and regeneration. 
MICRORNA IN 2012
Biotherapeutic potential of microRNAs in rheumatic diseases MicroRNAs (miRNAs) are small noncoding RNA molecules that modulate the expression of multiple protein-encoding genes at the post-transcriptional level. 1 These molecules participate in nearly every developmental and physiologic process. Although the function of most mammalian miRNAs has yet to be determined, it seems that their aberrant expression could have a role in the pathogenesis of several osteoarticular dis eases. 1 Several important insights in 2012 have impli cated specific miRNAs in the pathophysiology of osteoarthritis (OA) 2 and in TNF-driven 3 and nuclear factor κB (NFκB)-driven 4 inflammation. These miRNAs are involved in chondrogenic differentiation pathways as well as in the immune response, and are putative therapeut ic targets. miRNAs are naturally produced by cells. 1 They are derived from primary miRNA transcripts that are processed in the nucleus to form precursor miRNA (pre-miRNA), a hairpin loop of about 70 nucleo tides. The pre-miRNAs are then transported to the cyto plasm where they are cleaved to produce a miRNA-miRNA* duplex of 20-22 nucleotides in length. This duplex is unwound by a helicase, and the miRNA 'guide' strand is then incorporated into the multiprotein RNA-induced silencing complex (RISC) to function as a so-called mature miRNA, whilst the 'passenger' strand (miRNA*) is released and degraded. Mature miRNAs participate in gene silencing by regulating the stability or translational efficiency of target messenger RNA (mRNA). Depending on the degree of complementarity in basepairing between the miRNA and the target mRNA, the miRNA either represses translation (through imperfect pairing) or cleaves the mRNA (through perfect pairing). miRNAs have been shown to have a role in maintaining cartilage homeostasis during development, and also to be dysregulated in OA. No efficient structure-modifying therapy is available for OA, a disease that results from cartilage degeneration, chondro cyte hypertrophy and synovitis. miRNA profiling in human cartilage has identified miRNA targets with relevance to. Expression of miR-140, for example, is decreased in OA cartilage in comparison with normal human cartilage, and miR140 knockout mice develop OA-like pathology with age.
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5 By contrast, miR-146a is strongly induced in IL-1β-stimulated OA chondrocytes, 6 and miR-199* induces chondrogenesis through targeting of SMAD1 and cyclooxygenase-2 in human chondrocytes.
7
Multipotent mesenchymal stem cells, in particular adipose-derived stem cells (ADSCs), have been shown to be chondroprotective through anti-inflammatory and antifibrotic properties, to protect cells from oxidative stress, to prevent senescence, and to stimulate proliferation and differentiation of chondrocytes in co-culture through the release of growth factors. 8 These findings have opened the way for novel therapeutic applications combining stromal cells and miRNA delivery for the treatment of various disorders, including OA. In their 2012 paper, Jun Xu and colleagues 2 showed that levels of miR-194 decreased during chondrogenic differentiation of human ADSCs. The downregulation of miR-194 increased expression of SOX5 (a key transcription factor for cartilage differentiation) at protein level and resulted in enhanced chondrogenic differentiation of human ADSCs (Figure 1) . The researchers also found that miR-194 was upregulated in IL-1β-induced OA, and was associated with a decrease in SOX5 expression. These data suggest that miRNAs are involved in OA pathophysiology and potentially have a role in induction of chondrogenesis.
Rheumatoid arthritis (RA), an inflammatory autoimmune disorder related to chronic synovitis, is a multifactorial disease. The identification of a key causal role for miRNAs in chronic inflammation and the pathogenesis of RA might lead to the develop ment of a novel therapeutic strategy. Many studies have demonstrated the upregulation of several miRNAs either in
Key advances
■ miR-194 is reportedly involved in the pathophysiology of osteoarthritis and potentially has a role in induction of chondrogenesis 2 ■ miR-323-3p is overexpressed in synovial fibroblasts both from patients with rheumatoid arthritis and from transgenic mice with TNF-driven arthritis, and might regulate the Wnt-cadherin pathway 3 ■ miR-23b is a central regulator of inflammation in resident tissue cells during autoimmunity
